John Huiskamp

Director at ORF Biologics.

Raised on ORF Biologics filings

$1.7M

of $2.5M offered across 1 Form D filing

Company

Biotech · Tiffin, IA

Custom recombinant proteins and contract manufacturing

Custom recombinant proteins and contract manufacturing

ORF Biologics Form D filings
Filed	Security	Sold of offered	Filing
Jul 31, 2026	Equity	$1.7M/ $2.5M	Form D

Also named on ORF Biologics filings